{"entity":{"id":"nct07669454","kind":"trial","name":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.","aka":[],"tldr":"A phase 3 trial of Nuvastatic 300 in colorectal cancer, run by Natureceuticals Sdn Bhd, now recruiting.","summary":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy. is a phase 3 interventional study registered as NCT07669454 by Natureceuticals Sdn Bhd, with 250 participants planned, started 2025-10-01 and due to reach its primary completion in 2026-10-31. Interventions recorded: Nuvastatic 300 and Placebo.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07669454","url":"https://clinicaltrials.gov/study/NCT07669454"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["natureceuticals"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07669454","phase":"3","setting":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.","sponsor":"Natureceuticals Sdn Bhd","participation":[{"nct":"NCT07669454","source":"https://clinicaltrials.gov/study/NCT07669454","fetchedAt":"2026-10-07T16:55:56.330Z","studySha256":"11dbaf4d3d99a91c8e1c8d43d4b219ca2f7a9eaf55494cd0dbee6245b628fb99","overallStatus":"RECRUITING","lastUpdatePosted":"2026-06-25","leadSponsor":"Natureceuticals Sdn Bhd","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"65 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":250,"enrolmentType":"ESTIMATED","siteCount":6,"recruitingSiteCount":6,"countries":["India"]}],"started":"2025-10-01","startedType":"actual","enrolled":250,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07669454/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"company":[{"id":"natureceuticals","kind":"company","name":"NatureCeuticals","route":"/companies/natureceuticals/"}]}}